Literature DB >> 19570654

Beat-to-beat heart rate and QT interval variability in first episode neuroleptic-naive psychosis.

Ripu D Jindal1, Matcheri S Keshavan, Kevin Eklund, Angela Stevens, Debra M Montrose, Vikram K Yeragani.   

Abstract

INTRODUCTION: Though increased risk of sudden death in patients with schizophrenia is well-documented, the mechanisms remain unclear. Recent studies report two known risk factors for sudden cardiac death and other arrhythmias in schizophrenia, i.e., decreased RR interval variability (RRV) and increased QT interval variability (QTV). However, these studies did not control for the effects of medication. Herein, we report the results of our study comparing RRV and QTV in first episode neuroleptic-naive psychosis patients with healthy matched controls.
METHODS: 24 patients with first episode neuroleptic naïve psychosis were matched with 26 healthy controls on age and gender. After an overnight fast, all participants underwent an electrocardiogram recording in the morning.
RESULTS: In comparison with matched controls, patients with first episode neuroleptic-naïve psychosis had significantly increased QTV corrected for RRV, and decreased RRV.
CONCLUSIONS: The observed alterations in RRV and QTV may reflect impaired cardiac autonomic function that could underlie risk for abnormal ventricular repolarization and thereby increase the risk of sudden death and other arrhythmias. Our data suggest that RRV and QTV alterations may be independent of medication effects in first episode psychosis patients.

Entities:  

Mesh:

Year:  2009        PMID: 19570654      PMCID: PMC2829670          DOI: 10.1016/j.schres.2009.06.003

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  47 in total

1.  Effects of newer atypical antipsychotics on autonomic neurocardiac function: a comparison between amisulpride, olanzapine, sertindole, and clozapine.

Authors:  M W Agelink; T Majewski; C Wurthmann; K Lukas; H Ullrich; T Linka; E Klieser
Journal:  J Clin Psychopharmacol       Date:  2001-02       Impact factor: 3.153

2.  Task Force on Sudden Cardiac Death of the European Society of Cardiology.

Authors:  S G Priori; E Aliot; C Blomstrom-Lundqvist; L Bossaert; G Breithardt; P Brugada; A J Camm; R Cappato; S M Cobbe; C Di Mario; B J Maron; W J McKenna; A K Pedersen; U Ravens; P J Schwartz; M Trusz-Gluza; P Vardas; H J Wellens; D P Zipes
Journal:  Eur Heart J       Date:  2001-08       Impact factor: 29.983

3.  Heart-rate variability (HRV) in the ECG trace of routine EEGs: fast monitoring for the anticholinergic effects of clozapine and olanzapine?

Authors:  G W Eschweiler; M Bartels; G Längle; B Wild; I Gaertner; M Nickola
Journal:  Pharmacopsychiatry       Date:  2002-05       Impact factor: 5.788

4.  Course and prognostic implications of QT interval and QT interval variability after primary coronary angioplasty in acute myocardial infarction.

Authors:  H Bonnemeier; F Hartmann; U K Wiegand; F Bode; H A Katus; G Richardt
Journal:  J Am Coll Cardiol       Date:  2001-01       Impact factor: 24.094

Review 5.  A review of MRI findings in schizophrenia.

Authors:  M E Shenton; C C Dickey; M Frumin; R W McCarley
Journal:  Schizophr Res       Date:  2001-04-15       Impact factor: 4.939

6.  Electrodermically nonresponsive schizophrenia patients make more errors in the Stroop Color Word Test, indicating selective attention deficit.

Authors:  Eleomar Ziglia Lopes-Machado; José Alexandre de Souza Crippa; Jaime Eduardo Cecílio Hallak; Francisco Silveira Guimarães; Antonio Waldo Zuardi
Journal:  Schizophr Bull       Date:  2002       Impact factor: 9.306

7.  Twenty-four-hour QT interval variability: increased QT variability during sleep in patients with panic disorder.

Authors:  Vikram Kumar Yeragani; Robert Pohl; Richard Balon; V C Jampala; Anusha Jayaraman
Journal:  Neuropsychobiology       Date:  2002       Impact factor: 2.328

8.  Effect of fluoxetine, pemoline and placebo on heart period and QT variability in normal humans.

Authors:  Robert Pohl; Richard Balon; Anusha Jayaraman; Ronald G Doll; Vikram Yeragani
Journal:  J Psychosom Res       Date:  2003-09       Impact factor: 3.006

Review 9.  Neurobiology of emotion perception II: Implications for major psychiatric disorders.

Authors:  Mary L Phillips; Wayne C Drevets; Scott L Rauch; Richard Lane
Journal:  Biol Psychiatry       Date:  2003-09-01       Impact factor: 13.382

10.  Influences of an anticholinergic antiparkinsonian drug, parkinsonism, and psychotic symptoms on cardiac autonomic function in schizophrenia.

Authors:  Takashi Okada; Motomi Toichi; Morimitsu Sakihama
Journal:  J Clin Psychopharmacol       Date:  2003-10       Impact factor: 3.153

View more
  12 in total

1.  Relation between beat-to-beat QT interval variability and T-wave amplitude in healthy subjects.

Authors:  Muhammad A Hasan; Derek Abbott; Mathias Baumert
Journal:  Ann Noninvasive Electrocardiol       Date:  2012-07       Impact factor: 1.468

2.  QT dynamics during treatment with sertindole.

Authors:  Jimmi Nielsen; Fan Wang; Claus Graff; Jørgen K Kanters
Journal:  Ther Adv Psychopharmacol       Date:  2015-02

3.  The paradox of premature mortality in schizophrenia: new research questions.

Authors:  Hiram Joseph Wildgust; Richard Hodgson; Mike Beary
Journal:  J Psychopharmacol       Date:  2010-11       Impact factor: 4.153

4.  Exercise reveals the interrelation of physical fitness, inflammatory response, psychopathology, and autonomic function in patients with schizophrenia.

Authors:  Stefanie Ostermann; Marco Herbsleb; Steffen Schulz; Lars Donath; Sandy Berger; Daniela Eisenträger; Tobias Siebert; Hans-Josef Müller; Christian Puta; Andreas Voss; Holger W Gabriel; Kathrin Koch; Karl-Jürgen Bär
Journal:  Schizophr Bull       Date:  2012-09-10       Impact factor: 9.306

Review 5.  Autonomic nervous system dysfunction in psychiatric disorders and the impact of psychotropic medications: a systematic review and meta-analysis.

Authors:  Gail A Alvares; Daniel S Quintana; Ian B Hickie; Adam J Guastella
Journal:  J Psychiatry Neurosci       Date:  2016-03       Impact factor: 6.186

6.  QT interval variability in body surface ECG: measurement, physiological basis, and clinical value: position statement and consensus guidance endorsed by the European Heart Rhythm Association jointly with the ESC Working Group on Cardiac Cellular Electrophysiology.

Authors:  Mathias Baumert; Alberto Porta; Marc A Vos; Marek Malik; Jean-Philippe Couderc; Pablo Laguna; Gianfranco Piccirillo; Godfrey L Smith; Larisa G Tereshchenko; Paul G A Volders
Journal:  Europace       Date:  2016-01-27       Impact factor: 5.214

7.  Beat-to-beat vectorcardiographic analysis of ventricular depolarization and repolarization in myocardial infarction.

Authors:  Muhammad A Hasan; Derek Abbott; Mathias Baumert
Journal:  PLoS One       Date:  2012-11-14       Impact factor: 3.240

8.  A role for autonomic cardiac control in the effects of oxytocin on social behavior and psychiatric illness.

Authors:  Daniel S Quintana; Andrew H Kemp; Gail A Alvares; Adam J Guastella
Journal:  Front Neurosci       Date:  2013-04-02       Impact factor: 4.677

Review 9.  Etiology of cardiovascular disease in patients with schizophrenia: current perspectives.

Authors:  Murat Emul; Tevfik Kalelioglu
Journal:  Neuropsychiatr Dis Treat       Date:  2015-10-01       Impact factor: 2.570

10.  QT is longer in drug-free patients with schizophrenia compared with age-matched healthy subjects.

Authors:  Kumiko Fujii; Yuji Ozeki; Hiroaki Okayasu; Yumiko Takano; Takahiro Shinozaki; Hiroaki Hori; Masami Orui; Minoru Horie; Hiroshi Kunugi; Kazutaka Shimoda
Journal:  PLoS One       Date:  2014-06-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.